๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pain experienced by patients with terminal head and neck carcinoma

โœ Scribed by Yoav P. Talmi; Alexander Waller; Michaela Bercovici; Zeev Horowitz; M. Raphael Pfeffer; Abraham Adunski; Jona Kronenberg


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
83 KB
Volume
80
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Data pertaining to tumor origin, spread, treatment, and results were defined. Pain was assessed with the McGill Pain Questionnaire, using a 10-1 Department of Otolaryngology-Head and Neck point visual analogue scale (VAS) and a body map. Pain was diagnosed according Surgery, the Chaim Sheba Medical Center, Tel to cause and type. Treatment was selected according to the guidelines provided Hashomer, Israel.

in the WHO analgesic ladder.


๐Ÿ“œ SIMILAR VOLUMES


Immunoglobulin allotypes in patients wit
โœ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB ๐Ÿ‘ 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant

Impact of comorbidity on outcome of youn
โœ Bhuvanesh Singh; Mahesh Bhaya; Marc Zimbler; Jordan Stern; J. Thomas Roland; Ric ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 2 views

Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by